<section id ="1126461-1130960" class="mfp-hide modal-dialog modal-content overlay-def"><header class="modal-header"><h2 class="modal-title">SOR/2019-121, s. 2</h2></header><div class="modal-body"><p class="Section amending" id="1126461"><strong><a class="sectionLabel" id="s-2"><span class="sectionLabel">2</span></a></strong> Item 9 of Part 1 of Schedule VI to the Act is replaced by the following:</p><section><div class="AmendedText"><figure><ul class="noBullet"><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">9</span> </div><div class="listItemText2">3,4-Methylenedioxyphenyl-2-propanone (1-(1,3-benzodioxole)-2-propanone), its derivatives and analogues and salts of derivatives and analogues, including:</div></div><figure><ul class="noBullet"><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">(1)</span> </div><div class="listItemText2">methyl 3-(1,3 benzodioxol-5-yl)-2-methyloxirane-2-carboxylate (MMDMG)</div></div></li></ul></figure></li></ul></figure></div></section></div></section>